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Addictive drugs remodel the brain’s reward circuitry, the mesocorticolimbic dopamine (DA)
system, by inducing widespread adaptations of glutamatergic synapses. This drug-induced
synaptic plasticity is thought to contribute to both the development and the persistence
of addiction. This review highlights the synaptic modifications that are induced by in vivo
exposure to addictive drugs and describes how these drug-induced synaptic changes may
contribute to the different components of addictive behavior, such as compulsive drug
use despite negative consequences and relapse. Initially, exposure to an addictive drug
induces synaptic changes in the ventral tegmental area (VTA). This drug-induced synaptic
potentiation in the VTA subsequently triggers synaptic changes in downstream areas of
the mesocorticolimbic system, such as the nucleus accumbens (NAc) and the prefrontal
cortex (PFC), with further drug exposure. These glutamatergic synaptic alterations are
then thought to mediate many of the behavioral symptoms that characterize addiction.
The later stages of glutamatergic synaptic plasticity in the NAc and in particular in the
PFC play a role in maintaining addiction and drive relapse to drug-taking induced by drug-
associated cues. Remodeling of PFC glutamatergic circuits can persist into adulthood,
causing a lasting vulnerability to relapse. We will discuss how these neurobiological
changes produced by drugs of abuse may provide novel targets for potential treatment
strategies for addiction.
Keywords: addiction, drugs of abuse, synaptic plasticity, glutamate, dopamine, ventral tegmental area, nucleus
accumbens, prefrontal cortex
INTRODUCTION
For a long time, addiction was not perceived as a disease, but
as a personal choice. Therefore, little effort went into finding
appropriate treatment strategies for drug-dependent individuals.
In the last decades people have come to realize that addictive drugs
cause pathological changes in brain function, and that addiction is
a chronic medical disorder. Addiction, or “substance use disorder”
as described in the DSM-5 (American Psychiatric Association,
2013), is characterized by compulsive drug use despite negative
consequences and high rates of relapse. Globally, an estimated
27 million people are problem drug users of opiates, cocaine,
cannabis or amphetamines and 1 in every 100 deaths among
adults is attributed to illicit drug use (United Nations Office on
Drugs and Crime, 2014). Furthermore, WHO estimates that the
social cost of illicit substance use was around 2% of the gross
domestic product in 2004 in countries that have measured it
(World Health Organisation, 2008). Most of these costs were
associated with drug-related crime. Although the European drug
landscape has remained relatively stable in recent years, drug use
in Europe remains high by historical standards (EMCDDA, 2013).
On top of that, the costs and mortality as a direct consequence of
the use of socially accepted drugs, such as tobacco smoking and
drinking alcohol, are enormous. According to the WHO, tobacco
kills nearly 6 million people each year and 3.3 million people
die every year due to harmful use of alcohol. This does not take
into account the causal relationships between both harmful use of
alcohol and tobacco smoking and a range of mental and behav-
ioral disorders (Volkow and Li, 2005). All in all, the global burden
of addiction is immense. Unfortunately, current treatments for
drug addiction are still relatively ineffective. To improve treatment
strategies, it is important to better understand the neurobiological
changes that underlie addiction.
Although the brain circuitry underlying addiction is complex,
it is well established that the brain’s reward circuitry, or more
specifically, the mesocorticolimbic dopamine (DA) system, plays
an important role. The mesocorticolimbic system consists of the
ventral tegmental area (VTA) and the brain regions that are
innervated by projections from the VTA, such as the nucleus
accumbens (NAc), the prefrontal cortex (PFC), the amygdala,
and the hippocampus (Swanson, 1982). The mesocorticolimbic
system is crucial for reward and reinforcement processing, moti-
vation, and goal-directed behavior (Schultz, 1998; Wise, 2004). All
addictive drugs act on the mesocorticolimbic system, increasing
DA levels in this system (Di Chiara and Imperato, 1988). Different
types of drugs increase mesocorticolimbic DA levels through
distinct cellular mechanisms. Nicotine increases DA levels by
directly stimulating VTA DA neurons through α4β2-containing
nicotinic receptors (Maskos et al., 2005). Several other drugs,
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such as benzodiazepines, opioids and cannabinoids, exert their
effect by inhibiting GABAergic interneurons in the VTA, thereby
reducing inhibition on the DA neurons (Johnson and North,
1992; Szabo et al., 2002; Tan et al., 2010). Psychostimulants, such
as cocaine and amphetamine, increase extracellular DA levels
by interacting with the DA transporter, thereby inhibiting DA
reuptake (Williams and Galli, 2006). The increase in mesocor-
ticolimbic DA levels mediates the acute reinforcing effects of
addictive drugs. It does however not explain the long-lasting
behavioral abnormalities that are seen in addiction, since these
are still present once the drugs have been cleared from the body
and the DA levels have returned to normal. The development
and expression of addictive behaviors are caused by lasting drug-
induced neuroadaptations in the mesocorticolimbic system.
Accumulating evidence indicates that drugs indeed induce
long-lasting changes in the brain. More specifically, drugs of
abuse modify synaptic transmission in the mesocorticolimbic sys-
tem. This phenomenon is called drug-induced synaptic plasticity
(Lüscher and Malenka, 2011). This review focuses on synaptic
plasticity induced by in vivo exposure to drugs of abuse. Although
many types of synapses are modified by addictive drugs, addictive
drugs are thought to mainly alter glutamatergic transmission
(Lüscher, 2013). Furthermore, drug-induced synaptic plasticity
of glutamatergic transmission has been extensively studied. We
will highlight recent findings on drug-induced synaptic plasticity
of glutamatergic transmission, with the aim to elucidate what
the common mechanisms behind these synaptic adaptations are,
and how these drug-induced synaptic changes contribute to the
different aspects of addictive behavior.
EARLY CHANGES IN SYNAPTIC TRANSMISSION
SYNAPTIC PLASTICITY IN THE VENTRAL TEGMENTAL AREA (VTA)
Changes in synaptic transmission already occur after the first
exposure to an addictive drug. A single in vivo exposure to
an addictive drug induces an increase in synaptic strength at
glutamatergic synapses onto DA neurons of the VTA. A single
noncontingent injection of cocaine was administered in vivo to
mice and rats, and 24 h later, excitatory postsynaptic currents
(EPSCs) were recorded in dopaminergic neurons in midbrain
slices of these animals to monitor changes in synaptic strength
(Ungless et al., 2001). The ratio of AMPAR- vs. NMDAR-mediated
EPSCs (AMPAR/NMDAR ratio) in VTA DA neurons was signifi-
cantly increased. This increase can reflect an increase in AMPAR
currents or a decrease in NMDAR currents or a combination of
both. In fact, increased AMPAR currents and decreased NMDAR
currents both occur and cause the increased AMPAR/NMDAR
ratio after exposure to an addictive drug. Ungless et al. (2001)
demonstrated that AMPAR transmission was enhanced at glu-
tamatergic synapses onto DA neurons of the VTA, since both
the amplitude and frequency of AMPAR-mediated miniature
EPSCs (mEPSCs) were significantly increased after in vivo expo-
sure to cocaine. This was further supported by the finding that
exogenously applied AMPA to VTA DA neurons led to larger
AMPA-induced currents in slices from mice that had received
a cocaine injection than in slices from mice that were injected
with saline. Importantly, the cocaine-induced long-term poten-
tiation of AMPAR-mediated currents was demonstrated to be
specific for DA neurons of the VTA, since no potentiation was
found in the hippocampus or in GABA neurons in the VTA.
Cocaine-induced increases in the AMPAR/NMDAR ratio did
not occur when cocaine was co-administered with an NMDAR
antagonist, showing that the increase in the AMPAR/NMDAR
ratio depends on NMDAR activation. Thus, a single exposure
to cocaine induces synaptic plasticity at excitatory synapses on
VTA DA neurons that is similar to NMDAR-dependent long-
term potentiation (LTP). In line with this, drug-induced synaptic
plasticity occludes subsequent LTP, suggesting that these two
types of plasticity share underlying mechanisms (Ungless et al.,
2001; Liu et al., 2005; Argilli et al., 2008; Luu and Malenka,
2008).
After the discovery of in vivo cocaine-induced plasticity, it
was investigated whether other drugs of abuse elicit the same
changes in excitatory transmission in the VTA. From in vitro
studies it was already known that application of even a low dose
of nicotine induces LTP at excitatory synapses onto VTA DA
neurons (Mansvelder and McGehee, 2000), supporting this idea.
Indeed, all addictive drugs tested to date (among which mor-
phine, nicotine, benzodiazepines and ethanol) induce a potenti-
ation of AMPAR transmission in VTA DA neurons 24 h after in
vivo administration of a single dose (Saal et al., 2003; Tan et al.,
2010). AMPAR/NMDAR ratios were not increased after in vivo
administration of the non-addictive psychoactive drugs fluoxetine
and carbamazepine (Saal et al., 2003). The fact that different drug
classes, with different molecular mechanisms of action, induce a
similar type of synaptic plasticity in VTA DA neurons was a first
indication that this form of synaptic plasticity might be related to
the addictive properties of these drugs.
Further research into the mechanisms underlying the
increased AMPAR/NMDAR ratios showed that NMDAR-
activation needed for the drug-induced synaptic plasticity occurs
through stimulation of DA D5 receptors, since no cocaine-
induced potentiation was found after application of a D1/D5
receptor antagonist or in D5 receptor knockout mice (Argilli
et al., 2008). Nicotine-induced synaptic plasticity in vitro also
depends on DA D5 receptors (Mao et al., 2011). The enhanced
AMPAR transmission is caused by the insertion of GluA2-lacking
AMPARs into the synapse following in vivo exposure to addictive
drugs (Bellone and Lüscher, 2006; Argilli et al., 2008). Early
work by Fitzgerald et al. (1996) already provided an indication
that drug-induced plasticity at glutamatergic synapses onto
DA neurons of the VTA involved a switch to GluA2-lacking
AMPARs. Expression of GluA1 subunits, but not GluA2 subunits,
was increased in VTA DA neurons after exposure to cocaine
(Fitzgerald et al., 1996). To find more direct evidence of a switch
to GluA2-lacking AMPARs, Bellone and Lüscher (2006) made
use of the distinct biophysical characteristics of GluA2-lacking
AMPARs. GluA2-lacking AMPARs are Ca2+-permeable, have
greater conductance, are inwardly rectifying and are blocked by
polyamines (Washburn and Dingledine, 1996; Isaac et al., 2007).
The rectification of AMPAR-mediated EPSCs was increased
following cocaine administration, and administration of the
polyamine toxin Joro spider toxin (JST) partially blocked
AMPAR-mediated EPSCs in cocaine-treated mice, confirming
the insertion of GluA2-lacking AMPARs (Bellone and Lüscher,
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2006). These receptors could be inserted on top of the existing
pool of GluA2-containing AMPARs or they could replace GluA2-
containing receptors, keeping the total number of AMPARs at
the synapse constant. Immunogold labeling of GluA2 subunits
showed that the cytoplasmic pool of GluA2-containing AMPARs
was enhanced after exposure to cocaine, while GluA2 labeling at
the synapse was reduced (Mameli et al., 2007). Thus, exposure
to addictive drugs causes an exchange of GluA2-containing for
GluA2-lacking AMPARs, which potentiates AMPAR transmission
because of the higher single-channel conductance of the GluA2-
lacking AMPARs.
Originally, studies that reported a drug-induced potentia-
tion of AMPAR-mediated transmission in VTA DA neurons
were performed 24 h after drug administration, but what is
the actual time course of synapse strengthening following drug
exposure? Argilli et al. (2008) found that synaptic plasticity
occurred more rapidly after administration, since AMPAR poten-
tiation was found to be present within 3 h (Argilli et al., 2008).
Cocaine-induced synaptic plasticity is transient, since synaptic
potentiation was still observed after 5 days, but not after 10
days (Ungless et al., 2001). Since transmission at glutamatergic
synapses onto VTA DA neurons is normalized after approxi-
mately a week, a process counteracting the drug-induced changes
must be involved. Interestingly, cocaine-induced synaptic plas-
ticity is reversed by activation of mGluR1 receptors in the VTA.
More specifically, intraperitoneal injection of a positive mod-
ulator of mGluR1 reversed cocaine-induced AMPAR subunit
redistribution (Bellone and Lüscher, 2006). Local disruption of
mGluR1 function in neurons of the VTA on the other hand
prolonged the cocaine-evoked potentiation in the VTA (Mameli
et al., 2009). Thus, following exposure to drugs, glutamatergic
synaptic transmission is normalized by mGluR-dependent LTD,
which consists of a replacement of GluA2-lacking AMPARs with
lower conductance GluA2-containing AMPARs (Mameli et al.,
2007).
Thus far, enhanced AMPAR transmission has been dis-
cussed as a reason for the increased AMPAR/NMDAR ratios
induced by in vivo drug exposure. However, the insertion
of the GluA2-lacking AMPARs would actually decrease the
AMPAR/NMDAR ratio at +40 mV, since GluA2-lacking AMPARs
conduct poorly at positive membrane potentials due to polyamine
block. Therefore, the increased AMPAR/NMDAR ratios must
partly be caused by a decrease in NMDAR currents. Indeed,
increased AMPAR/NMDAR ratios were also found to be due to
a decrease in NMDAR transmission (Mameli et al., 2011). This
decrease results from a NMDAR subunit composition switch.
GluN2B to GluN2A ratios are increased following exposure to
cocaine (Yuan et al., 2013). Furthermore, GluN3A-containing
NMDARs, which have very low Ca2+ permeability, are inserted
into the synapse after cocaine exposure (Yuan et al., 2013).
Together, these findings suggest that cocaine drives the synaptic
insertion of tri-heteromeric GluN1/GluN2B/GluN3A-containing
NMDARs that replace GluN1/GluN2As and GluN1/GluN2A/
GluN2Bs. Both cocaine-induced changes in AMPAR transmission
and cocaine-induced changes in NMDAR transmission were
found to be dependent on insertion of GluN3A-containing
NMDARs, since no cocaine-induced plasticity was present
in GluN3A knockout mice or after injection of an adeno-
associated viral vector expressing an anti-GluN3A short-hairpin
RNA (Yuan et al., 2013). Finally, mGluR1 activation, which
reverses cocaine-induced AMPAR subunit redistribution, also
reversed NMDAR subunit redistribution (Yuan et al., 2013).
Thus, the synaptic insertion of GluN3A-containing AMPARs
appears to be essential for the expression of cocaine-induced
plasticity.
In addition to glutamatergic inputs, VTA DA neurons also
receive GABAergic inputs, from local interneurons and from
projections from the NAc and the ventral pallidum (VP; Kalivas
et al., 1993; Steffensen et al., 1998). These inhibitory synapses onto
VTA DA neurons also undergo synaptic plasticity after exposure
to addictive drugs. Morphine, cocaine and nicotine were all shown
to impair long-term potentiation of GABAergic synapses onto
VTA DA neurons, albeit with different time courses (Niehaus
et al., 2010). On the other hand, GABAergic inputs to inhibitory
interneurons in the VTA are potentiated after in vivo exposure to
drugs, thereby disinhibiting DA neurons (Tan et al., 2010; Bock-
lisch et al., 2013). Together, the increased AMPAR/NMDAR ratio
at glutamatergic synapses onto VTA DA neurons, the loss of LTP
of GABAergic synapses onto VTA DA neurons, and the disinhibi-
tion of VTA DA neurons by potentiation of GABAergic synapses
onto VTA interneurons are likely to enhance the excitability of
VTA DA neurons. In the case of nicotine, GABAergic input onto
VTA DA neurons is further decreased by desensitization of nico-
tinic acetylcholine receptors (nAChRs) on GABAergic neurons
(Mansvelder et al., 2002). Since activation of nAChRs depolarizes
GABAergic neurons, this desensitization leads to a depression of
GABAergic transmission. This effect is the greatest in the subset
of GABAergic neurons that are normally excited by endogenous
cholinergic transmission. The depression of GABAergic inputs
due to nAChR desensitization may contribute to an increase in
VTA DA neuron excitability, although more complex interactions
between GABA and DA neuron activity seem to play a role (Tolu
et al., 2013).
Drug-induced synaptic plasticity in the VTA does not occur
globally, affecting all VTA DA neurons equally. Recent findings
have shown that drugs differentially affect different subpopula-
tions of VTA DA neurons with projections to different target areas
(Lammel et al., 2013). A single injection of cocaine selectively
modified glutamatergic synapses on DA neurons projecting to
the NAc shell but not synapses on DA neurons projecting to
the mPFC (Lammel et al., 2011). Excitatory synapses on DA
neurons projecting to the mPFC were however changed by an
aversive stimulus, suggesting that rewarding and aversive stimuli
affect different DA neuron subpopulations in the VTA. The DA
neurons projecting to the NAc shell, which are affected by drugs,
receive their input from the laterodorsal tegmentum, while the DA
neurons projecting to the mPFC, which are affected by aversive
stimuli, receive their input from the lateral habenula (Lammel
et al., 2012).
Single in vivo exposures to drugs of abuse induce synaptic
changes that are still present long after the drugs have been
cleared from the body, at least 5 days. However, this is too
short-lived to explain the long-lasting behavioral effects that are
seen in addiction. Even after repeated cocaine administration
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(seven daily injections), the cocaine-induced increase in the
AMPAR/NMDAR ratio in VTA DA neurons is transient and can
no longer be observed ten days after the cessation of cocaine
administration, just as the synaptic potentiation induced by a
single injection (Borgland et al., 2004). However, in all these
studies noncontingent drug administration was used. The effect
of self-administration of addictive drugs is longer lasting than
the effect of noncontingent drug administration. After 3 months
of abstinence from cocaine self-administration, cocaine-induced
synaptic potentiation was still present in VTA DA neurons in rats
(Chen et al., 2008). This persistence of the drug-induced synaptic
potentiation in VTA neurons after drug self-administration sug-
gests that this phenomenon could be a fundamental factor driving
the development of addictive behavior.
What are the direct behavioral changes that are induced by
drug-induced synaptic plasticity in the VTA? Mice with a genetic
deletion of the GluA1 subunit or the GluN1 subunit selectively in
DA neurons lacked drug-induced plasticity in VTA DA neurons,
but cocaine still induced normal conditioned place preference
(CPP) and behavioral sensitization in these mice (Engblom et al.,
2008). In another study, mice lacking the GluN1 subunit exclu-
sively in DA neurons also showed normal behavioral sensitization,
but CPP was abolished in these mice (Zweifel et al., 2008),
in contrast with the results from Engblom et al. (2008). This
discrepancy between the studies could be caused by differences in
CPP protocols. All in all, evidence that the drug-induced synaptic
plasticity in VTA DA neurons mediates short-term behavioral
effects of drug exposure is very limited. However, the drug-
induced synaptic plasticity in VTA DA neurons may be an impor-
tant first step for late-stage addictive behaviors. In mice lacking
GluN1 in DA neurons, reinstatement of drug seeking behavior
in CPP was abolished (Engblom et al., 2008). Furthermore, the
delayed enhancement of behavioral sensitization that occurs after
prolonged cocaine withdrawal did not occur in GluN1 knockout
mice (Zweifel et al., 2008). These late-stage behavioral changes
are probably not direct consequences of the synaptic plasticity
in the VTA, but are more likely caused by synaptic changes in
other brain areas that are triggered by the synaptic plasticity
in the VTA. Drug-induced synaptic plasticity in the VTA leads
to subsequent synaptic plasticity in other brain areas, which is
more important for the behavioral changes seen in addiction
than the synaptic plasticity in the VTA itself (see below). In
the VTA, drugs of abuse alter the rules for activity-dependent
plasticity and thereby enable subsequent downstream changes
throughout the mesocorticolimbic circuitry (Creed and Lüscher,
2013). These changes in downstream brain regions, in particular
in the NAc and the PFC, are then thought to be associated
with the long-lasting behavioral abnormalities that are seen in
addiction.
The capacity of the drug-induced synaptic plasticity in the
VTA to invert the rules for activity-dependent plasticity relies
on the redistribution of AMPAR and NMDAR subunits (Yuan
et al., 2013). Normally, LTP is NMDAR-dependent and is induced
when presynaptic glutamate release coincides with depolariza-
tion of the postsynaptic membrane, because the Mg2+-block
of the NMDARs is relieved at depolarized membrane poten-
tials, allowing Ca2+ entry. However, cocaine induces a switch
of NMDAR subunit composition, creating NMDARs that have
very low Ca2+ permeability (Yuan et al., 2013). Therefore, acti-
vation of NMDARs no longer induces LTP. On the other hand,
cocaine drives the synaptic insertion of GluA2-lacking AMPARs,
which are Ca2+-permeable. Therefore, after cocaine exposure,
a form of LTP can be induced in VTA neurons that relies on
calcium entry through AMPARs and is independent of NMDARs
(Mameli et al., 2011). However, GluA2-lacking AMPARs conduct
poorly at positive membrane potentials, due to polyamine block
at positive membrane potentials. The greater the hyperpolariza-
tion, the more readily GluA2-lacking AMPARs conduct calcium.
Therefore, cocaine causes the rules of activity-dependent synaptic
potentiation to change, since the induction of LTP now requires
a pairing of presynaptic activity with hyperpolarization of the
postsynaptic cell instead of depolarization (Mameli et al., 2011).
Whether this holds true for all drugs of abuse remains to be
tested.
As mentioned above, glutamatergic synaptic plasticity in the
VTA triggers subsequent synaptic plasticity in other parts of the
mesocorticolimbic system. Synaptic changes occur first in the
VTA before synaptic plasticity in other regions of the meso-
corticolimbic system. In addition, changes in the VTA occur
after a single exposure, whereas plasticity in downstream areas
generally requires multiple drug exposures (Kourrich et al., 2007),
although it needs to be noted that Mato et al. (2004) showed
that in mice, a single in vivo administration of THC altered
synaptic plasticity in the NAc (Mato et al., 2004). Furthermore,
cocaine-evoked synaptic plasticity in the NAc only occurs if
the synaptic plasticity in the VTA is persistent (Mameli et al.,
2009). Reversing synaptic plasticity in the VTA by intraperi-
toneal injection of a positive modulator of mGluR1 prevented
synaptic plasticity in the NAc (Mameli et al., 2009). On the
other hand, after local disruption of mGluR1 function in VTA
neurons, which prolongs drug-evoked potentiation in the VTA,
a single injection of cocaine was sufficient to induce synaptic
plasticity in the NAc, which is not normally the case. These
findings suggest a hierarchical organization of drug-induced
synaptic plasticity, with the VTA as first station of plasticity,
followed by glutamatergic synaptic plasticity in downstream
areas of the mesocorticolimbic system. Mechanisms underlying
these later stages of plasticity are discussed in the following
section.
LATER STAGES OF SYNAPTIC REMODELING
DRUG-INDUCED SYNAPTIC PLASTICITY IN THE NUCLEUS ACCUMBENS
The principal neurons of the NAc, the GABAergic medium
spiny neurons (MSNs), receive glutamatergic inputs from cortical
and limbic brain regions, including the PFC and the amyg-
dala (Groenewegen et al., 1999). Results from several studies
indicate that glutamatergic transmission in the NAc plays an
important role in drug seeking. Microinjection of AMPA into the
NAc elicits significant reinstatement of cocaine-seeking behavior,
while microinjection of an AMPAR antagonist into the NAc
prevents reinstatement of cocaine seeking (Cornish and Kali-
vas, 2000; Ping et al., 2008). Furthermore, activity within the
NAc is thought to mediate behavioral sensitization (Koya et al.,
2009, 2012). Since glutamatergic signaling in the NAc plays an
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important role in addictive behavior, synaptic plasticity at glu-
tamatergic synapses onto NAc MSNs is likely to be involved in
addiction.
In contrast to the VTA, a single cocaine injection is not
sufficient to induce synaptic plasticity in the NAc (Kourrich
et al., 2007). Only after repeated treatment with cocaine, changes
in synaptic strength occur at glutamatergic synapses on NAc
MSNs. The direction of this synaptic plasticity is dependent on
the duration of drug withdrawal (Kourrich et al., 2007). Kour-
rich et al. (2007) administered five once-daily cocaine injections
to male mice and assessed the AMPAR/NMDAR ratio in NAc
shell neurons both 24 h and 10–14 days after the last injection.
During early withdrawal, 24 h after the last injection, a sig-
nificant decrease in AMPAR/NMDAR ratios was found in NAc
shell neurons of cocaine-treated mice. However, after a drug-free
period of 10–14 days, AMPAR/NMDAR ratios were increased in
NAc shell neurons. Furthermore, a single drug re-exposure led
to a decrease in AMPAR/NMDAR ratios 1 day later, abruptly
reversing the synaptic potentiation. Synaptic depression following
an additional cocaine exposure after a drug-free period was also
described in earlier studies (Thomas et al., 2001; Brebner et al.,
2005). Thomas et al. (2001) furthermore showed that the decrease
in the AMPAR/NMDAR ratio reflects a reduction in AMPAR
transmission.
To determine the cause of increased AMPAR/NMDAR ratios
in NAc shell neurons after prolonged withdrawal, Kourrich
et al. (2007) recorded AMPAR-mediated mEPSCs. The amplitude
and frequency of AMPAR-mediated mEPSCs were significantly
increased in cocaine-treated mice (Kourrich et al., 2007), sug-
gesting a potentiation of AMPAR-mediated synaptic transmis-
sion after prolonged withdrawal. These results match findings
by Boudreau and Wolf (Boudreau and Wolf, 2005), who found
increased cell surface expression of AMPAR subunits in the NAc
of rats after 21 days of withdrawal. Although the exact mech-
anisms underlying this drug-induced synaptic potentiation in
the NAc shell after prolonged withdrawal are unknown, it is
known that the synaptic potentiation is dependent on activation
of the extracellular signal-regulated kinase (ERK) pathway by
way of ERK phosphorylation (Pascoli et al., 2012). The increased
frequency of AMPAR mEPSCs, combined with the finding that
the paired-pulse ratio (a measure for presynaptic function) was
unchanged, suggests that repeated exposure to cocaine may lead
to the formation of new synapses on NAc MSNs. This is sup-
ported by the finding that the number of dendritic spines on
NAc MSNs was increased after repeated exposure to cocaine,
amphetamine and nicotine (Robinson and Kolb, 2004). Thus,
repeated cocaine exposure produces synaptic potentiation in the
NAc shell that develops during drug withdrawal, possibly due
to formation of new synapses, which is followed by an abrupt
synaptic depression upon a single re-exposure. However, both
after prolonged withdrawal and after a single drug re-exposure,
NMDAR transmission was unaltered (Kourrich et al., 2007).
Furthermore, no evidence for a change in the presence of GluA2-
lacking AMPARs at the synapse was found, since the rectification
index of AMPAR-mediated EPSCs was unchanged in cocaine-
treated mice after prolonged withdrawal and after additional
cocaine exposure.
These studies used noncontingent drug administration to
elicit synaptic plasticity. Following cocaine self-administration,
synaptic depression of excitatory transmission was found in the
NAc shell during early withdrawal from cocaine (Schramm-
Sapyta et al., 2006), which was followed by increased AMPAR
transmission after prolonged withdrawal (Conrad et al., 2008).
However, in contrast to the findings by Kourrich et al. (2007),
this increase was found to be due to the synaptic insertion of
GluA2-lacking AMPARs. Both surface and intracellular GluA1
levels were significantly increased in the NAc after 45 days of
withdrawal, and inward rectification of AMPAR-mediated EPSCs
was significantly increased in the NAc core of cocaine-treated
rats (Conrad et al., 2008). GluA2 levels were not changed,
suggesting that GluA2-lacking AMPARs are inserted on top of
the existing pool of GluA2-containing AMPARs. Since Kourrich
et al., assessed synaptic changes after 10–14 days withdrawal,
whereas Conrad et al. checked synaptic changes after 42–47
days withdrawal, it is possible that the synaptic insertion of
GluA2-lacking AMPARs in the NAc only occurs after a sustained
period of withdrawal. This is in accordance with the finding
that NAc GluA1 levels were only slightly increased after 21 days
of withdrawal, indicating that GluA1 levels increase gradually
after withdrawal (Conrad et al., 2008). The study by Mameli
et al. (2009) supports the idea that GluA2-lacking AMPARs are
inserted into synapses after extended withdrawal from repeated
cocaine exposure. An increased rectification index was found in
NAc MSNs after 35 days of withdrawal after both noncontin-
gent cocaine administration and self-administration of cocaine
(Mameli et al., 2009). Thus, synaptic AMPAR subunit levels in
NAc MSNs are changing for several weeks following cocaine
exposure.
Both Thomas et al. (2001) and Kourrich et al. (2007) found
a significant decrease in AMPAR/NMDAR ratios in NAc shell
neurons of cocaine-treated mice during early withdrawal, which
was attributed to a decrease in AMPAR transmission (Thomas
et al., 2001). However, a decreased AMPAR/NMDAR ratio may
also be caused by the generation of silent synapses. Silent synapses
are glutamatergic synapses that contain NMDARs, but no func-
tional AMPARs (Isaac et al., 1995). Thomas et al. (2001) did
not find any cocaine-induced changes in NMDAR transmission,
but this does not exclude the possibility that the number of
silent synapses is increased by cocaine exposure. Indeed, fol-
lowing repeated noncontingent cocaine exposure the number
of silent synapses was increased in NAc shell MSNs (Huang
et al., 2009). These new silent synapses were gradually generated
during cocaine exposure, producing a significant increase in the
percentage of silent synapses from the third day of the cocaine
treatment. Cocaine-induced generation of silent synapses was
mediated by membrane insertion of new GluN2B-containing
NMDARs (Huang et al., 2009). Surface and total levels of GluN2B,
but not GluN2A, were increased, combined with an increased
surface level of obligatory GluN1 subunits. Furthermore, after
selectively inhibiting GluN2B-containing NMDARs, no increase
in silent synapses could be detected. During withdrawal, the
number of silent synapses declined again (Huang et al., 2009).
However, this does not necessarily mean that the generated
synapses disappeared again. It could also mean that newly
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generated silent synapses were unsilenced by synaptic insertion of
(GluA2-lacking) AMPARs. This might be one of the mechanisms
behind the increased cell surface expression of AMPAR subunits
and the increased AMPAR/NMDAR ratio in NAc shell neurons
after prolonged withdrawal. Thus, the observed changes in the
AMPAR/NMDAR ratio and the observed changes in the number
of silent synapses might go hand in hand. Furthermore, the
generation of silent synapses may facilitate subsequent synaptic
plasticity.
The behavioral relevance of decreases in AMPAR/NMDAR
ratios during early withdrawal is not yet clear. It has been pro-
posed that the drug-induced synaptic depression might cause
NAc shell neurons to be less sensitive to natural rewarding stim-
uli, which could result in feelings of anhedonia and dysphoria
(Van den Oever et al., 2012). This might increase drug craving.
The behavioral consequence of synaptic depression following a
single drug re-exposure is thought to be the acute expression
of behavioral sensitization (Brebner et al., 2005). Blocking the
induction of synaptic depression by intra-NAc infusion of a
membrane permeable peptide that disrupts endocytosis of GluA2
prevented increased locomotor activity induced by amphetamine
re-exposure.
The gradual potentiation of AMPAR transmission during
prolonged withdrawal may mediate “incubation of drug crav-
ing”, the phenomenon that cue-induced craving and drug
seeking increase progressively over the first months after with-
drawal from abused drugs (Grimm et al., 2001). Potentiation
of AMPAR transmission enhances the responsiveness of NAc
MSNS to drug-associated cues, leading to enhanced cue-induced
drug craving and drug seeking. Cue-induced cocaine-seeking
after prolonged withdrawal from cocaine self-administration
was decreased by injecting a selective blocker of GluA2-lacking
AMPARs into the NAc (Conrad et al., 2008). Furthermore,
internalization of GluA2-lacking AMPARs at amygdala-to-NAc
synapses by in vivo optogenetic stimulation after prolonged
withdrawal decreased incubation of cocaine craving (Lee et al.,
2013). The effect of this internalization was the re-silencing of
some of the unsilenced synapses, suggesting that the matura-
tion of silent synapses also contributes to incubation of cocaine
craving.
The described drug-induced synaptic changes in the NAc led
Bellone and Lüscher (2012) and Dong and Nestler (2014) to
propose a hypothesis of rejuvenation of synaptic transmission
during cocaine addiction, creating types of synapses that are
normally associated with early brain development (Bellone and
Lüscher, 2012; Dong and Nestler, 2014). Examples are the gen-
eration of silent synapses and the synaptic insertion of GluA2-
lacking AMPARs. Exposure to cocaine reopens a critical period of
synapse development in the mesocorticolimbic system. Younger
synapses have a higher ability to undergo long-lasting experience-
dependent plastic changes. This is thought to explain how drugs
can elicit such strong and unusually long-lasting plastic changes,
leading to equally strong and durable drug-associated memo-
ries (Dong and Nestler, 2014). The rejuvenation hypothesis also
extends to synaptic changes in the VTA, such as the re-emergence
of GluN3A-containing NMDARs. The fact that younger synapses
have a higher ability to undergo experience-dependent plastic
changes might also explain why younger people are more vulner-
able to addiction.
Glutamatergic synaptic plasticity does not only occur during
drug exposure and withdrawal. It also occurs during cue-induced
relapse to drug seeking. The presentation of cocaine-associated
cues in the absence of cocaine was found to elicit rapid increases
in both the dendritic spine size and the AMPAR/NMDAR ratio
in the NAc core of rats that had a history of cocaine self-
administration (Gipson et al., 2013a). These increases were
already present 15 min after the presentation of the cocaine-
associated cue and the increase of the AMPAR/NMDAR ratio
and the spine head diameter at 15 min were positively cor-
related with the intensity of drug seeking. This suggests that
the rapid cue-induced synaptic potentiation in NAc core MSNs
might be a mechanism that triggers relapse. Two hours after
initiating cue-induced reinstatement, the dendritic spine size and
the AMPAR/NMDAR ratio had returned to pre-relapse levels.
Activity in the prelimbic cortex (PL), a subregion of the medial
PFC (mPFC) that sends glutamatergic projections to the NAc
core, was shown to be crucially involved, since microinjection of
GABAR agonists into the PL prevented both cue-induced synaptic
changes and drug seeking (Gipson et al., 2013a). Whether cue-
induced activity of glutamatergic PL-to-NAc synapses is sufficient
to trigger actual relapse, or whether cue-induced synaptic changes
are necessary as well for relapse remains to be determined. How-
ever, a recent study argues for a causal link between cocaine-
induced plasticity of glutamatergic mPFC-to-NAc synapses and
relapse (Pascoli et al., 2014).
The impact of cue-induced activity at glutamatergic PL-to-
NAc synapses is enhanced by the reduction in basal extracellular
glutamate levels in the NAc associated with withdrawal from
addictive drugs (Gipson et al., 2014). Basal extracellular glutamate
levels in the NAc are reduced after both contingent and non-
contingent cocaine and nicotine exposure due to downregulated
activity of the glial cystine–glutamate exchanger, which transports
glutamate to the extracellular space (Kalivas, 2009). This results
in decreased glutamate tone on presynaptic inhibitory mGluR2
and mGluR3 receptors, which in turn decreases inhibition of
presynaptic glutamate release (Gipson et al., 2014). This leads to
an increased synaptic release of glutamate in response to drug-
associated cues. Furthermore, the released glutamate is not effi-
ciently removed from the synapse, because the expression of the
glial glutamate transporter 1 (GLT-1), which mediates glutamate
uptake, is diminished following exposure to drugs (Knackstedt
et al., 2010; Shen et al., 2014). Thus, drug-associated cues give
rise to excessive amounts of glutamate in NAc glutamatergic
synapses, which may explain why these cues can have such a
strong behavioral effect.
In addition to directly modifying synaptic strength in the
NAc, drugs of abuse are also thought to alter the capacity
of NAc synapses to undergo subsequent synaptic plasticity.
Cocaine addiction is associated with an impairment of NMDAR-
dependent LTP and LTD at glutamatergic synapses in the NAc
core (Martin et al., 2006; Moussawi et al., 2009; Kasanetz
et al., 2010). LTD was impaired in the NAc core, but not in
the NAc shell, after 21 days of abstinence in rats that had
self-administered cocaine (Martin et al., 2006). Drug-induced
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impairments in synaptic plasticity may contribute to inflexi-
ble, compulsive behaviors that are characteristic of addiction
and might explain drug consumption despite negative health
consequences in humans. The relevance of impaired NMDAR-
dependent LTD with regard to cocaine addiction was emphasized
by the finding that only cocaine self-administering rats that
developed addiction-like behaviors showed persistently impaired
LTD, while LTD was recovered in animals that maintained a
controlled drug intake (Kasanetz et al., 2010). Similar results were
found after self-administration of ethanol. NMDAR-dependent
LTD was significantly impaired after protracted withdrawal in
ethanol-sensitized mice, but not in ethanol-treated mice that
failed to develop this behavioral adaptation (Abrahao et al.,
2013). D-serine, a co-agonist of the NMDAR, might play a
role in the drug-induced impairment in NMDAR-dependent
synaptic plasticity (D’Ascenzo et al., 2014). D-serine is essential
for NMDAR-dependent LTP and LTD in the NAc core and D-
serine levels are reduced in the NAc core of cocaine-treated
rats (Curcio et al., 2013). In slices from cocaine-treated rats,
perfusion with D-serine fully restored LTP and LTD induction.
Thus, cocaine-induced deficits in NMDAR-dependent synaptic
plasticity in the NAc are due, at least partially, to reduced D-serine
levels.
As in the VTA, there is some evidence that drugs do not only
cause global synaptic changes in the NAc, but can also differen-
tially affect different subpopulations of MSNs (Wolf and Ferrario,
2010; Creed and Lüscher, 2013). Synaptic potentiation in the NAc
shell that develops during drug withdrawal is thought to selec-
tively occur at synapses onto D1-receptor-expressing MSNs, and
not at synapses onto D2-receptor-expressing MSNs (Pascoli et al.,
2012). Recently, it was found that this synaptic potentiation at
synapses onto D1-receptor-expressing MSNs is dependent on the
formation of D1R/GluN1 complexes (Cahill et al., 2014). Blocking
D1R/GluN1 association, while preserving individual D1R and
NMDAR-dependent signaling, prevented ERK activation, which
is required for the synaptic potentiation.
SYNAPTIC PLASTICITY IN THE MEDIAL PREFRONTAL CORTEX
Another main target of DA projections originating in the VTA
is the medial prefrontal cortex (mPFC). The pyramidal neu-
rons of the mPFC receive glutamatergic projections from many
different brain areas, including the basolateral nucleus of the
amygdala (BLA), and send glutamatergic projections to the VTA,
the NAc and back to the BLA (Gabbott et al., 2005; Hoover and
Vertes, 2007; Van den Oever et al., 2010). Addiction is associated
with decreased basal PFC neuronal activity, or “hypofrontality”
(Volkow et al., 2003), which can also be seen in rats after repeated
cocaine self-administration (Sun and Rebec, 2006). The mPFC
can be divided into a dorsal (including the PL) and a ventral part
(including the infralimbic cortex) that have different anatomi-
cal and functional characteristics (Van den Oever et al., 2012).
Anatomically, the dorsal mPFC is thought to predominantly
innervate the NAc core, while the ventral mPFC sends projec-
tions to the NAc shell (Heidbreder and Groenewegen, 2003).
The dorsal and ventral mPFC are also thought to play different
roles in addiction. Activity in the dorsal mPFC is thought to
initiate drug seeking and is crucial for cue-induced relapse to
drug seeking (Gipson et al., 2013b). On the other hand, activity
in the ventral mPFC can suppress drug-seeking responses (Peters
et al., 2008; LaLumiere et al., 2012). As a whole, the mPFC is
therefore thought to play an important role in the control of
relapse behavior.
Only few studies investigating drug-evoked synaptic plas-
ticity in the mPFC have been performed. Therefore, we have
only limited knowledge about the role of drug-induced synap-
tic plasticity in the mPFC. In vitro studies have shown that
nicotine can increase the threshold for the induction of spike-
timing-dependent potentiation at glutamatergic synapses onto
mouse mPFC layer V pyramidal neurons by enhancing GABAer-
gic inputs to these neurons (Couey et al., 2007). In contrast,
5 days after withdrawal from repeated noncontingent cocaine
exposure (seven daily injections), the induction of LTP was facil-
itated at excitatory synapses onto rat mPFC layer V pyramidal
neurons due to reduced GABA input (Lu et al., 2010). This
was mediated by a brain-derived neurotrophic factor (BDNF)-
induced reduction of surface expression of GABAA receptors
in the mPFC, leading to suppression of GABAergic inhibition.
Although the behavioral relevance of this enhanced plasticity was
not extensively investigated, there is some indirect evidence that
the facilitation of LTP induction in the mPFC might contribute
to behavioral sensitization after cocaine withdrawal (Lu et al.,
2010).
Despite the reduction of mPFC LTP by acute application of
nicotine, induction of synaptic potentiation in mPFC is facil-
itated by nicotine withdrawal, similar to cocaine. During and
immediately following in vivo nicotine treatment, glutamater-
gic synaptic potentiation was reduced in the mPFC of ado-
lescent rats, while this LTP was significantly increased in the
mPFC of adult rats 5 weeks after they received nicotine treat-
ment during adolescence (Goriounova and Mansvelder, 2012).
Bidirectional effects of nicotine exposure during adolescence on
synaptic potentiation are most likely mediated by bidirectional
changes in synaptic levels of the inhibitory metabotropic gluta-
mate receptor 2 (mGluR2). Following nicotine exposure during
adolescence, protein levels of mGluR2 in rat mPFC synaptic
membranes were increased on the first day of withdrawal, but
decreased 5 weeks after nicotine exposure (Counotte et al., 2011).
Using mGluR2 agonists, nicotine-induced enhancement of synap-
tic potentiation could be blocked, while mGluR2 antagonists
facilitated synaptic potentiation (Goriounova and Mansvelder,
2012).
The short-term block of LTP induction is likely to also be
caused by a transient increase in the expression of nAChRs
containing α4 and β2 subunits in the mPFC acutely after nicotine
exposure during adolescence, which is the mechanism behind
the enhanced GABAergic inhibition that causes this block of
LTP (Counotte et al., 2012). Interestingly, the increase in the
expression of nAChRs containing α4 and β2 subunits in the rat
mPFC was only found after nicotine exposure during adolescence,
and not after nicotine exposure during adulthood (Counotte
et al., 2012). Similarly, the study by Goriounova and Mansvelder
(2012) demonstrated a difference between the effects of nicotine
exposure during adolescence and during adulthood. Nicotine
exposure during adulthood did not lead to lasting changes in
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LTP. In line with this, adolescent nicotine exposure, but not
postadolescent nicotine exposure, leads to diminished attentional
performance and increments in impulsive action 5 weeks after
treatment in rats (Counotte et al., 2009, 2011). Nicotine exposure
during adolescence elicits a lasting reduction in synaptic mGluR2
levels and enhancement of timing-dependent long-term potenti-
ation in the rat mPFC that may cause cognitive deficits during
adulthood. Altogether, these studies indicate that adolescence is a
critical period of vulnerability for long-term effects of nicotine on
the PFC.
After prolonged withdrawal, changes in glutamate receptor
subunit distribution were seen in several studies. For example,
increased expression of GluA2/3, GluA4, and GluN2B in the
mPFC was reported after 2 weeks of abstinence from binge
cocaine self-administration (Tang et al., 2004). However, no long-
term effect on the synaptic membrane expression of glutamate
receptor subunits in the mPFC was found after heroin self-
administration (Van den Oever et al., 2008). It is possible that
changes in glutamate receptor subunit distribution after pro-
longed withdrawal only arise after extended access to drugs. This
is supported by the study by Ben-Shahar et al. (2009), who again
found increased GluN2B expression after 2 weeks of abstinence,
but only in rats that had had extended daily access to cocaine
(Ben-Shahar et al., 2009).
Since the mPFC is thought to play an important role in
cue-induced relapse to drug seeking, it was also investigated
whether synaptic plasticity occurs in the mPFC at the moment
of cue-induced relapse to drug seeking. Re-exposure to heroin-
associated cues after 3 weeks of abstinence from heroin self-
administration induced rapid synaptic depression in the mPFC
of rats (Van den Oever et al., 2008). The synaptic membrane
expression of AMPAR subunits GluA2 and GluA3 in the mPFC
was reduced, and the expression of clathrin-coat assembly protein
AP2m1, which is involved in clathrin-dependent endocytosis, was
increased. This suggests that the re-exposure to heroin-associated
cues induced clathrin-mediated endocytosis of GluA2/GluA3
AMPARs. Furthermore, a decreased AMPAR/NMDAR ratio and
an increased rectification index were found in mPFC pyra-
midal neurons, confirming the occurrence of endocytosis of
GluA2-containing AMPARs. In these assessments, dissociations
between the dorsal and ventral mPFC were not made. Therefore,
it is not known whether the cue-induced synaptic depression
occurs in the entire mPFC or only in one of the subregions.
However, the behavioral effect of blocking cue-induced endocy-
tosis of GluA2-containing AMPARs was assessed separately for
both mPFC subregions. Interestingly, blocking GluA2 endocy-
tosis specifically in the ventral mPFC attenuated cue-induced
relapse to heroin seeking, while blocking GluA2 endocytosis in
the dorsal mPFC did not (Van den Oever et al., 2008). This
suggests that the rapid endocytosis of GluA2-containg AMPARs
and the resulting synaptic depression in the ventral mPFC are
crucial for cue-induced relapse to heroin seeking. This fits with
the idea that the ventral mPFC exerts inhibitory control over
drug seeking. All in all, it can be hypothesized that cue-induced
synaptic depression in the ventral mPFC impairs inhibitory
control over drug seeking, thereby mediating relapse to heroin
seeking.
DRUG-INDUCED SYNAPTIC PLASTICITY IN THE HUMAN
BRAIN
Drug-induced synaptic plasticity in the rodent mesocorticolim-
bic system contributes to the development and persistence of
addiction. Do drugs of abuse actually induce synaptic plastic-
ity in the human brain? Human imaging studies have shown
that addiction in humans involves changes in activity in the
same brain areas in which synaptic changes have been shown
in animal models of addiction (Van den Oever et al., 2012).
Although these studies did not directly investigate synaptic plas-
ticity, they do show that addiction causes enduring adaptations
in the mesocorticolimbic system in humans. Only few studies
have directly investigated plasticity of glutamatergic synapses in
the human brain, and, as a result, evidence of drug-induced
synaptic plasticity is sparse. Experimentally, timing-dependent
plasticity of motor-evoked potentials (MEPs) can be induced in
human subjects by pairing peripheral nerve stimulation (PNS,
analogous to presynaptic stimulation) with a transcranial mag-
netic stimulation (TMS) of the motor cortex (Stefan et al.,
2000, 2002; Wolters et al., 2003; De Beaumont et al., 2012;
Lu et al., 2012). Such paired associative stimulation (PAS) can
induce both LTP-like increases and LTD-like decreases in MEP
amplitude, depending on the relative timing of associated stimuli
(Wolters et al., 2003, 2005; Thabit et al., 2010; De Beaumont
et al., 2012; Lu et al., 2012; Conde et al., 2013; Koch et al.,
2013). At the synaptic level, it was found that in surgically
resected human brain tissue, cortical glutamatergic synapses can
undergo both LTP and LTD throughout adulthood, in response
to similar timing regimes as was used for PAS in human sub-
jects (Testa-Silva et al., 2010, 2014; Verhoog et al., 2013). This
plasticity of adult human synapses was dependent on postsy-
naptic NMDARs and L-type voltage-gated calcium channels.
Grundey et al. (2012) used PAS in human subjects and found that
during nicotine withdrawal, LTP-like synaptic plasticity induced
by PAS was abolished in smokers, but that it could be res-
cued by administration of a nicotine patch (Grundey et al.,
2012). This suggests that mechanisms of drug-induced synaptic
plasticity may also play a role in the human brain. Clearly,
more studies in human subjects and in surgically resected liv-
ing human brain tissue are needed to verify that drug-induced
synaptic changes found in rodents indeed also play a role in
the human brain. Some successes have already been achieved
though in trials in human addicts for treatments inspired by
rodent research, as we will discuss below, supporting the idea
that drug-induced synaptic changes and their behavioral conse-
quences are indeed relevant for the development of addiction
treatments.
NOVEL TARGETS FOR POTENTIAL TREATMENT STRATEGIES
FOR ADDICTION
Can drug-induced synaptic plasticity be a target for potential
treatments of human addiction? We will discuss some ideas
based on rodent addiction research why plasticity might actually
offer promising targets. Since drug-induced synaptic plasticity in
the VTA represents a first step in a cascade of synaptic changes
throughout the mesocorticolimbic system, an early intervention
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at the level of the VTA might prevent synaptic changes in down-
stream brain regions such as the NAc. In rodents, cocaine-induced
synaptic plasticity in the VTA can be reversed by activation of
mGluR1 receptors (Bellone and Lüscher, 2006). Stimulation of
mGluR1 receptors produces a form of mGluR-dependent LTD,
which consists of a replacement of GluA2-lacking AMPARS with
lower conductance GluA2-containing AMPARs (Mameli et al.,
2007). This normalizes synaptic transmission. Furthermore, this
type of mGluR-dependent LTD also reverses the cocaine-induced
redistribution of NMDARs (Yuan et al., 2013). Selectively
preventing synaptic plasticity in the VTA is sufficient to prevent
subsequent synaptic plasticity in the NAc and to attenuate
cue-induced cocaine seeking after prolonged withdrawal in
mice (Mameli et al., 2009), suggesting that this strategy can be
efficacious in the treatment of cocaine addiction in the rodent
brain. In the NAc, mGluR1 positive modulators can also reverse
the drug-induced synaptic plasticity that is seen after prolonged
withdrawal (Wolf and Tseng, 2012). Therefore, mGluR1s might
not only be a potential target to treat early stages of addiction,
but might also act at later stages of the disease and attenuate
incubation of drug craving. Whether mGluR1 activation actually
reduces drug taking, drug craving and relapse in rodents still
requires investigation. Also, whether mGluR1 activation normal-
izes synaptic strength in the VTA following synaptic plasticity
induced by other drugs of abuse than cocaine is not known.
Another promising potential target is the acid-sensing ion
channel 1A (ASIC1A), which inhibits cocaine-evoked synaptic
plasticity in the NAc (Kreple et al., 2014). ASIC1A activity also
attenuates addiction-related behavior. Overexpressing ASIC1A in
rat NAc reduced cocaine self-administration while disruption of
ASIC1A increased both morphine-CPP and cocaine-CPP in mice
(Kreple et al., 2014). Enhancing ASIC1A function might therefore
be beneficial in the treatment of addiction. ASIC1A function is
thought to be reduced by the enzyme carbonic anhydrase IV
(CA-IV), which has a role in the regulation of extracellular pH
buffering in the brain (Kreple et al., 2014). Therefore, compounds
such as CA-IV inhibitor acetazolamide that enhance ASIC1A
function, might be a promising lead to follow.
A different strategy that might prove beneficial in the treat-
ment of addiction is to rescue drug-induced deficits in NMDAR-
dependent synaptic plasticity in the NAc, which contribute
to inflexible, compulsive behaviors characteristic of addiction
(D’Ascenzo et al., 2014). Since the deficits in NMDAR-dependent
synaptic plasticity in the NAc are thought to be at least partially
due to reduced D-serine levels, targeting D-serine signaling may
hold promise for the treatment of drug addiction. D-serine levels
can for example be restored by administration of an inhibitor
of the enzyme D-amino acid oxidase, which degrades D-serine
(D’Ascenzo et al., 2014). Thus far, the role of D-serine has only
been studied in the context of cocaine addiction. Whether D-
serine is also involved in addiction to other types of drugs of abuse
is not known.
Many addiction treatments have limited success due to high
relapse rates. Therapeutic strategies focusing on reducing relapse
rates would therefore be promising. Given the role of the
mPFC in control of relapse behavior, novel treatment strategies
could be aimed at reducing activity in the dorsal mPFC or
at enhancing glutamatergic transmission in the ventral mPFC.
In particular, agents that inhibit cue-induced endocytosis of
GluA2-containing AMPARs might be useful to prevent relapse.
This was done in rat mPFC with a TAT peptide, TAT-GluR23γ
(Van den Oever et al., 2008), which prevented GluA2-containing
AMPAR endocytosis and reduced cue-induced heroin seeking in
these rats.
Instead of reducing activity in the dorsal mPFC, another
approach for preventing cue-induced relapse could be to reduce
the impact of this activity at glutamatergic mPFC-to-NAc
synapses in the NAc. During withdrawal from addictive drugs,
extracellular glutamate levels in the NAc are reduced, which
enhances the amount of glutamate that is released in mPFC-
to-NAc synapses after exposure to drug-associated cues (Gipson
et al., 2014). Furthermore, reduced GLT-1 levels diminish gluta-
mate uptake from the synapse. Restoring GLT-1 and extracellular
glutamate levels could be a way to prevent cue-induced relapse.
One of the compounds that restores levels of GLT-1 and extra-
cellular glutamate in the NAc is the antioxidant N-acetylcysteine
(NAC; Gipson et al., 2014). NAC treatment has already been
tested in human addicts, and was found to reduce drug craving
and cocaine use (LaRowe et al., 2007; Mardikian et al., 2007).
CONCLUSION AND FUTURE DIRECTIONS
Drug-induced synaptic modifications contribute to the develop-
ment and persistence of addiction. Although our knowledge on
drug-induced synaptic plasticity is far from complete, a picture
is emerging in which glutamatergic synaptic plasticity in meso-
corticolimbic areas plays an important role in drug addiction
(Figure 1). Initially, exposure to an addictive drug induces synap-
tic changes in the VTA. In VTA DA neurons, drug exposure
results in synaptic insertion of high conductance GluA2-lacking
AMPARs in exchange for lower conductance GluA2-containing
AMPARs. This drug-induced synaptic potentiation in the VTA
subsequently triggers synaptic changes in downstream areas of
the mesocorticolimbic system (such as the NAc, the PFC, and
the amygdala) with further drug exposure. These synaptic adap-
tations then mediate many of the behavioral symptoms that char-
acterize addiction. The decreased AMPAR/NMDAR ratio in the
NAc during early withdrawal might mediate feelings of needing
the drug to feel happy, by making neurons less sensitive to nat-
ural rewarding stimuli. The subsequent gradual potentiation of
AMPAR transmission, the gradual maturation of silent synapses,
and the reduced basal extracellular glutamate levels in the NAc
all mediate the expression of incubation of cue-induced craving,
by enhancing the responsiveness of NAc MSNs to drug-associated
cues. Future studies in which synaptic modifications (and their
behavioral consequences) are investigated in both NAc core and
shell are needed to dissociate the role of NAc core and shell in
this working model. The drug-induced synaptic adaptations in
the PFC play an important role in relapse. Rapid cue-induced
synaptic depression in the ventral mPFC impairs response inhi-
bition upon exposure to drug-associated cues, thereby mediat-
ing relapse to drug seeking. Drug-induced neuroadaptations in
the dorsal mPFC on the other hand act to enhance excitatory
output from this subregion to NAc core, which drives drug
seeking.
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FIGURE 1 | Working model of the role of drug-induced synaptic
plasticity in the mesocorticolimbic system in drug addiction.
Simplified schematic of the mesocorticolimbic brain areas known to
be affected by drug-induced plasticity, important synaptic
modifications that occur in these brain areas and the behavioral
consequences of these modifications. AMG, amygdala; NAc, nucleus
accumbens; (m)PFC, (medial) prefrontal cortex; VTA, ventral
tegmental area.
More research is needed to verify and extend this work-
ing model, since the synaptic changes that are induced by
addictive drugs are numerous and complex. Several important
questions remain unanswered. For instance, drug-evoked synap-
tic plasticity has been predominantly studied in the VTA and
NAc, but our knowledge on synaptic changes in the mPFC
and their behavioral consequences is still limited. In addi-
tion, what drug-induced neuroadaptations take place in other
brain areas that play a role in addiction, such as the amygdala
and habenula (Maroteaux and Mameli, 2012; Van den Oever
et al., 2012; Lecca et al., 2014), where plasticity can also be
very prominent? The majority of the studies discussed in this
review specifically examined cocaine-induced synaptic plastic-
ity. Do the findings generalize to other drugs of abuse? This
is especially important since different types of drugs can have
different effects on synaptic transmission (Wolf and Ferrario,
2010). Another unresolved issue is the neural basis of indi-
vidual differences in vulnerability to drug addiction. Studies
that compare effects of addictive drugs in animals that develop
addiction-like behaviors with the effects of addictive drugs in
animals that do not may contribute to finding the synap-
tic correlates of addiction vulnerability (Kasanetz et al., 2010;
Abrahao et al., 2013). Finally, drugs of abuse can differentially
affect subpopulations of neurons within a specific brain region
(Wolf and Ferrario, 2010; Creed and Lüscher, 2013). It will be
exciting to learn how heterogeneous responses of specific sub-
populations of neurons to drugs and drug-associated cues in
different mesocorticolimbic areas give rise to the various aspects
of addiction.
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